Weight Loss
Medically Supervised Weight Loss with Nurse Practitioner Amber Hough
Weight loss is not not just about shedding pounds but also about improving overall health and reducing the risks associated with obesity, such as heart disease, diabetes, and hypertension. Recently, groundbreaking medications like semaglutide, the active ingredient in Ozempic and Wegovy, and tirzepatide, the active ingredient in Mounjaro and Zepbound, have revolutionized weight management, offering new hope and possibilities.
Understanding Obesity and Its Risks
Obesity is more than a weight issue; it’s a complex health condition linked to numerous health risks. It’s associated with an increased likelihood of developing chronic diseases such as:
- Type 2 diabetes
- Heart disease
- Certain types of cancer
- Hypertension
- Sleep apnea
- Joint problems
- And more, significantly impacting an individual's quality of life.
Moreover, it can affect mental health, leading to issues like depression and low self-esteem. Understanding these risks underscores the importance of addressing obesity with comprehensive and sustainable weight management strategies.
Book Appointment
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Semaglutide and Tirzepatide: Game Changers in Weight Management
Discover how semaglutide and tirzepatide have transformed the landscape of weight loss treatments, providing an effective tool for those struggling with weight management. Both drugs offer promising results for patients looking to achieve and maintain a healthier weight, each with a unique mechanism of action that supports weight loss in conjunction with lifestyle changes.
Semaglutide
The active ingredient in Ozempic for diabetes treatment and Wegovy for weight management, semaglutide is a GLP-1 receptor agonist. It works by mimicking an intestinal hormone that triggers the pancreas to release insulin more efficiently, slows down gastric emptying, and reduces appetite. These effects together aid in controlling blood sugar levels and promoting weight loss.
Tirzepatide:
A newer player in the field of weight management, Tirzepatide, the active ingredient in Mounjaro and Zepbound, is a dual GIP and GLP-1 receptor agonist. It not only enhances the action of insulin, similar to GLP-1 receptor agonists, but also leverages the effects of GIP to improve blood sugar control and promote weight loss. By acting on two fronts, Tirzepatide offers a robust approach to managing weight.
Under the guidance of nurse practitioner Amber Hough, FNP-C, individuals can explore these options to find a comprehensive weight loss plan tailored to your needs, lifestyle and goals as well as paving the way for a healthier, more vibrant life.
Under the guidance of nurse practitioner Amber Hough, FNP-C, individuals can explore these options to find a comprehensive weight loss plan tailored to your needs, lifestyle and goals as well as paving the way for a healthier, more vibrant life.
Benefits of Amber's Medically Supervised Weight Loss Program
- Expert Guidance: Benefit from Amber's expertise in weight management and her personalized approach to care.
- Holistic Support: Receive support in all aspects of your weight loss journey, from diet to lifestyle changes.
